|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 199.15 USD | +0.12% |
|
-7.85% | +13.16% |
| 08/07 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 08/07 | BofA Securities Adjusts Biogen Price Target to $217 From $203 | MT |
| Market Cap | 2.94TCr 2.57TCr 2.37TCr 2.19TCr 4.16TCr 2,80400Cr 4.23TCr 28TCr 11TCr 1,38100Cr 11TCr 11TCr 4,74900Cr | P/E 2026 * |
30.3x | P/E 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.49TCr 3.05TCr 2.82TCr 2.6TCr 4.94TCr 3,33000Cr 5.02TCr 34TCr 13TCr 1,64000Cr 13TCr 13TCr 5,63900Cr | EV / Sales 2026 * |
3.47x | EV / Sales 2027 * | 3.16x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | +0.12% | ||
| 1 week | -7.85% | ||
| Current month | -7.83% | ||
| 1 month | +2.53% | ||
| 3 months | +15.14% | ||
| 6 months | +6.15% | ||
| Current year | +13.16% |
| 1 week | 194.37 |  | 215.95 |
| 1 month | 193.2 | | 219.72 |
| Current year | 160.36 | | 219.72 |
| 1 year | 121.05 | | 219.72 |
| 3 years | 110.04 | | 281.68 |
| 5 years | 110.04 | | 358.77 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.12% | -7.85% | +47.16% | -29.27% | 2.94TCr | |
| -0.51% | +1.57% | +18.72% | -5.52% | 6.76TCr | |
| -5.16% | -8.63% | +37.37% | +202.27% | 5.16TCr | |
| +5.28% | +39.50% | +39.50% | +39.50% | 4.3TCr | |
| -2.10% | +0.89% | -49.30% | -53.47% | 4.09TCr | |
| -10.83% | -14.41% | +99.15% | -44.54% | 2.71TCr | |
| -1.53% | -0.13% | +65.92% | +88.58% | 2.33TCr | |
| +3.88% | +2.16% | +11.78% | +201.51% | 1.99TCr | |
| -1.59% | -1.63% | +61.04% | +130.75% | 1.69TCr | |
| -4.75% | +11.27% | +85.63% | +394.76% | 1.68TCr | |
| Average | -1.72% | -1.59% | +41.70% | +92.46% | 3.37TCr | |
| Weighted average by Cap. | -1.53% | -2.13% | +33.25% | +66.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.01TCr 879.42Cr 811.15Cr 749.18Cr 1.42TCr 96TCr 1.45TCr 9.69TCr 3.81TCr 47TCr 3.77TCr 3.69TCr 1,62400Cr | 1.04TCr 908.29Cr 837.78Cr 773.78Cr 1.47TCr 99TCr 1.49TCr 10TCr 3.93TCr 49TCr 3.9TCr 3.81TCr 1,67700Cr |
| Net income | 149.48Cr 130.75Cr 120.6Cr 111.39Cr 211.35Cr 14TCr 214.91Cr 1.44TCr 565.87Cr 7.02TCr 561.25Cr 549.04Cr 24TCr | 196.89Cr 172.22Cr 158.85Cr 146.71Cr 278.38Cr 19TCr 283.07Cr 1.9TCr 745.34Cr 9.25TCr 739.26Cr 723.17Cr 32TCr |
| Net Debt | 550.87Cr 481.85Cr 444.45Cr 410.49Cr 778.89Cr 53TCr 791.99Cr 5.31TCr 2.09TCr 26TCr 2.07TCr 2.02TCr 89TCr | 338.49Cr 296.08Cr 273.09Cr 252.23Cr 478.6Cr 32TCr 486.65Cr 3.26TCr 1.28TCr 16TCr 1.27TCr 1.24TCr 55TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | $199.15 | +0.12% | 11,33,120 |
| 09/26/09 | $198.91 | -0.72% | 16,57,327 |
| 08/26/08 | $200.36 | -2.60% | 19,47,888 |
| 07/26/07 | $205.70 | -1.32% | 11,56,880 |
| 06/26/06 | $208.46 | -3.54% | 12,18,492 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
